Published in Mol Pharmacol on November 01, 1982
Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J (1995) 1.25
Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. Proc Natl Acad Sci U S A (1988) 1.11
Binding of [3H]forskolin to rat brain membranes. Proc Natl Acad Sci U S A (1984) 1.02
Characterization of the homologous and heterologous desensitization of rat Leydig-tumour-cell adenylate cyclase. Biochem J (1984) 0.91
Photoaffinity labeling of the beta-adrenergic receptor from cultured lymphoma cells with [125I]iodoazidobenzylpindolol: loss of the label with desensitization. Proc Natl Acad Sci U S A (1983) 0.88
Ca2+ channel currents in rat sensory neurones: interaction between guanine nucleotides, cyclic AMP and Ca2+ channel ligands. J Physiol (1991) 0.86
Vasoactive-intestinal-polypeptide-stimulated adenosine 3',5'-cyclic monophosphate accumulation in GH3 pituitary tumour cells. Reversal of desensitization by forskolin. Biochem J (1984) 0.83
Activation and stabilization of the catalytic unit of adenylate cyclase. Biochem J (1985) 0.77
Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells. Biochem J (1986) 0.77
Multiple non-specific effects of sphingosine on adenylate cyclase and cyclic AMP accumulation in S49 lymphoma cells preclude its use as a specific inhibitor of protein kinase C. Biochem J (1990) 0.76
Forskolin refractoriness. Exposure to the diterpene alters guanine nucleotide-dependent adenylate cyclase and calcium-uptake activity of cells cultured from the rat aorta. Biochem J (1987) 0.75
Cyclic AMP. Annu Rev Biochem (1968) 8.08
Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine. J Biol Chem (1965) 5.86
Adenyl cyclase as an adrenergic receptor. Ann N Y Acad Sci (1967) 4.64
Intracellular Ca2+ activates a fast voltage-sensitive K+ current in vertebrate sympathetic neurones. Nature (1982) 4.57
A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell (2001) 3.13
An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med (1990) 3.09
Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. J Biol Chem (1967) 3.03
Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells. J Biol Chem (1968) 2.88
Effects of prostaglandins on adenosine 3',5'-monophosphate levels in fat and other tissues. J Biol Chem (1968) 2.56
The effect of vasopressin and of theophylline on the concentration of adenosine 3',5'-phosphate in the urinary bladder of the toad. J Biol Chem (1965) 2.51
Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet (1997) 2.43
The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart. Mol Pharmacol (1965) 2.20
Mathematical model of an adult human atrial cell: the role of K+ currents in repolarization. Circ Res (1998) 2.18
A mathematical model of action potential heterogeneity in adult rat left ventricular myocytes. Biophys J (2001) 1.97
K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol (2005) 1.89
Role of adenosine 3',5'-monophosphate in the effects of insulin and anti-insulin serum on liver metabolism. J Biol Chem (1968) 1.88
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
The effects of the catecholamines, adrenergic blocking agents, prostaglandin E1, and insulin on cyclie AMP levels in the rat epididymal fat pad in vitro. Ann N Y Acad Sci (1967) 1.75
Role of an inwardly rectifying potassium current in rabbit ventricular action potential. J Physiol (1992) 1.74
Effect of insulin on adenosine 3',5'-monophosphate in the rat epididymal fat pad. J Biol Chem (1966) 1.72
Shal-type channels contribute to the Ca2+-independent transient outward K+ current in rat ventricle. J Physiol (1997) 1.65
Menkes disease: a biochemical abnormality in cultured human fibroblasts. Proc Natl Acad Sci U S A (1976) 1.60
Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology (2001) 1.59
Gluconeogenesis in the perfused liver. The effects of fasting, alloxan diabetes, glucagon, epinephrine, adenosine 3',5'-monophosphate and insulin. Am J Med (1966) 1.58
Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Med (1989) 1.57
The stimulatory effect of luteinizing hormone on adenosine 3',5'-monophosphate accumulation in corpus luteum slices. J Biol Chem (1966) 1.52
Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems. Antimicrob Agents Chemother (1988) 1.49
Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery (1998) 1.48
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology (2004) 1.48
The fine structural localization of glutamate decarboxylase in synaptic terminals of rodent cerebellum. Brain Res (1974) 1.48
Human minisatellites, repeat DNA instability and meiotic recombination. Electrophoresis (1999) 1.48
Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol Sci (1999) 1.46
Aortic stenosis, cesarean delivery, and epidural anesthesia. J Clin Anesth (1993) 1.45
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage (2002) 1.44
Role of sodium-calcium exchange in activation of contraction in rat ventricle. J Physiol (1993) 1.42
Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements. Circ Res (1995) 1.42
Review of invasive cervical cancer cases for AIDS surveillance. J Acquir Immune Defic Syndr (1994) 1.40
Isolation of Serratia plymuthica from a human burn site. J Clin Microbiol (1985) 1.39
A rapidly activating sustained K+ current modulates repolarization and excitation-contraction coupling in adult mouse ventricle. J Physiol (1997) 1.38
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology (2001) 1.32
Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol (1999) 1.32
Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. Mol Pharmacol (2000) 1.32
Localization of distinct surface antigens on Chlamydia trachomatis HAR-13 by immune electron microscopy with monoclonal antibodies. Infect Immun (1982) 1.31
beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem (1997) 1.30
Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin. Endocrinology (1969) 1.29
Central venous oxygen saturation in shock: a study in man. Anesthesiology (1972) 1.29
The chromatographic separation of ribonucleic acids. Biochim Biophys Acta (1966) 1.27
Involvement of adenosine 3',5'-monophosphate in release of ACTH. Am J Physiol (1969) 1.26
Adenylate cyclase coupling proteins are not essential for agonist-specific desensitization of lymphoma cells. J Biol Chem (1981) 1.25
Regulation of adenosine 3':5'-monophosphate content in human astrocytoma cells by adenosine and the adenine nucleotides. J Biol Chem (1974) 1.24
Biotyping and exoenzyme profiling as an aid in the differentiation of human from bovine group G streptococci. J Clin Microbiol (1984) 1.23
Value of blood agar for primary plating and clinical implication of simultaneous isolation of Aeromonas hydrophila and Aeromonas caviae from a patient with gastroenteritis. J Clin Microbiol (1984) 1.23
Cyclic nucleotides in cultured cells. Adv Cyclic Nucleotide Res (1975) 1.22
T-cell colonies recognize antigen in association with specific epitopes on Ia molecules. Nature (1982) 1.19
Acute respiratory insufficiency. Treatment with prolonged extracorporeal oxygenation. J Thorac Cardiovasc Surg (1972) 1.18
Regulation of unloaded cell shortening by sarcolemmal sodium-calcium exchange in isolated rat ventricular myocytes. J Physiol (1993) 1.17
Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes (2001) 1.17
The role of cyclic AMP in hormone actions. Adv Enzyme Regul (1968) 1.16
Generation of T cell colonies from responder strain 2 guinea pigs that recognize the copolymer L-glutamic acid, L-lysine in association with nonresponder strain 13 Ia antigens. J Exp Med (1982) 1.16
Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol (1998) 1.16
Cyclic 3',5'-nucleotide phosphodiesterase from bovine heart. Methods Enzymol (1974) 1.15
A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages. Cell (2000) 1.15
White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol (2007) 1.14
Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain (1999) 1.14
Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution. Mol Pharmacol (1996) 1.13
Regulation of adenosine 3':5'-cyclic monophosphate concentration in cultured human astrocytoma cells by catecholamines and histamine. Proc Natl Acad Sci U S A (1971) 1.12
Cyclic 3',5'-AMP and the lipolytic effects of hormones on adipose tissue. Pharmacol Rev (1966) 1.12
Biological causes and effects of paralytic shellfish poisoning. Lancet (1968) 1.12
Overlooked spine injuries associated with lumbar transverse process fractures. Clin Orthop Relat Res (1996) 1.11
Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. Brain Res (1976) 1.11
Abnormal regulation of adenosine 3',5'-monophosphate and corticosterone formation in an adrenocortical carcinoma. J Clin Invest (1969) 1.11
Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. Proc Natl Acad Sci U S A (1988) 1.11
Prevalence of gastrointestinal symptoms after bacterial gastroenteritis. Study did not include a control group. BMJ (1997) 1.10
The epidemiological importance of childhood cancers. Br Med Bull (1971) 1.10
Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat. Atherosclerosis (1973) 1.10
Selective block of calcium current by lanthanum in single bullfrog atrial cells. J Gen Physiol (1988) 1.09
Adverse events in health care: setting priorities based on economic evaluation. J Qual Clin Pract (1999) 1.09
Effect of epinephrine on cyclic adenosine 3',5'-phosphate and hexose phosphates in intestinal smooth muscle. Biochim Biophys Acta (1966) 1.08
Immunocytochemical localization of glutamate decarboxylase in rat spinal cord. J Comp Neurol (1975) 1.08
Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology (1969) 1.06
Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J Biol Chem (1997) 1.06
Endogenous GTP and the regulation of epinephrine stimulation of adenylate cyclase. J Cyclic Nucleotide Res (1978) 1.06
cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. J Biol Chem (1994) 1.05
Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol Pharmacol (1994) 1.05
Voltage-sensitive dye mapping in Langendorff-perfused rat hearts. Am J Physiol Heart Circ Physiol (2002) 1.05
The effects of epinephrine and prostaglandin E-1 on cyclic adenosine 3':5'-monophosphate levels in WI-38 fibroblasts. J Biol Chem (1974) 1.04
Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells. J Cyclic Nucleotide Res (1981) 1.04
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol (2004) 1.03
Desensitization of beta2-adrenergic receptors with mutations of the proposed G protein-coupled receptor kinase phosphorylation sites. J Biol Chem (1998) 1.02
Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes. Am J Physiol (1991) 1.02
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.02
Neuronal death in brain infarcts in man. Neuropathol Appl Neurobiol (2000) 1.01